Conceptual issues in the use of drugs for the treatment of aggression in man.
Violence is a symptom of an underlying mental state such as a psychosis, a characterological problem, or brain dysfunction. Thus drugs used to treat aggression in man exert effects by their specific pharmacological actions (e.g., antipsychotic, anticonvulsant). Most literature to date has dealt with animals and human models of aggression and lacks conceptual clarity. Aggression differs from depression, a coherent clinical entity, in its etiological diversity and its paroxysmal or impulsive basis, and this may account for the relationship seen in literature linking violence to epilepsy; yet literature on anticonvulsants is equivocal with regard to beneficial effects on aggression. Lithium has been shown to have positive effects, although its mode of action is unclear. A variety of antipsychotic agents and minor tranquilizers have been mentioned. Central nervous system stimulants have been found useful to treat hyperkinetic syndromes in both children and adults where aggression is a symptom. Hormonal agents are discussed. Drug treatment of aggression should not obscure the need for verbal therapies, and social and environmental factors should always be regarded.
D000293:Adolescent; D000328:Adult; D000374:Aggression / Q000187:drug effects*; D000435:Alcoholic Intoxication / Q000150:complications; D000818:Animals; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000188:drug therapy; D002090:Butyrophenones / Q000627:therapeutic use; D002188:Cannabis / Q000494:pharmacology; D002707:Chlordiazepoxide / Q000009:adverse effects; D004195:Disease Models, Animal; D004827:Epilepsy / Q000150:complications; D012739:Gonadal Steroid Hormones / Q000037:antagonists & inhibitors; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy; D007175:Impulsive Behavior; D008094:Lithium / Q000627:therapeutic use; D008297:Male; D008691:Methadone / Q000494:pharmacology; D010259:Paranoid Disorders / Q000139:chemically induced; D010640:Phenothiazines; D010672:Phenytoin / Q000627:therapeutic use; D011600:Psychopharmacology; D011612:Psychosurgery; D012559:Schizophrenia / Q000150:complications; D013888:Thiothixene / Q000627:therapeutic use; D014754:Violence
D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D014150:Antipsychotic Agents; D002090:Butyrophenones; D012739:Gonadal Steroid Hormones; D010640:Phenothiazines; D010672:Phenytoin; D002707:Chlordiazepoxide; D013888:Thiothixene; D008094:Lithium; D008691:Methadone